Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,669   2.87  Index Moved Up 0.17%
CSL MSB SRX SPL Compulsion Junk Bonds Data Storage Processed Foods 
United States GSPC USD ...  |  Company Directory


Processing
Collecting data for CSL

CSL Ltd quote and profile

 
 Companies |  Insiders  | Dashboard  
     
60.91
  
STOCK
0.06  Macroaxis: 0.1 Up   0.10%  
Year To Date
28.160.91
Trading Day 
60.5361.61
May 22 2013 

Diversification Suggestion

Use CSL Ltd to enhance returns of your portfolios. The stock experiences normal upward fluctuation
Check current 30 days CSL Ltd correlation with market (S&P 500)
1 Month Beta 0.0  
Unless we do not have data at the moment the returns on S&P 500 and CSL Ltd are completely uncorrelated
CSL Ltd not significant BetaCSL Ltd Beta Legend
CSL Australia Australian #AU000000CSL8AU
CSL Ltd
Healthcare
Biotechnology
Benchmark S&P 500
http://www.csl.com.au
Contact Number: 61 3 9389 1911
Currency: AUD - Australian Dollar
Traded on Australian Securities Exchange
    
Current Valuation26.35 B
Shares Outstanding498.19 M
Revenue4.76 B
Gross Profit2.06 B
 United States SP 500   0.17 % Macroaxis: 0.17 Moved Up  
 
 thisGreen CSL CSL.AX agains markets  0.10 % Macroaxis: 0.1 Moved Up  
 
 Australia All Or   0.29 % Macroaxis: 0.29 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

CSL Ltd Leadership

BS, MB CEO, Managing Director, Executive Director, Member of Nomination Committee, Member of Innovation and Devel. Committee and President of CSL (US) Inc
Brian McNamee CEO, Managing Director, Executive Director, Ph.D
John Shine Chairman of the Board
Paul Perreault President CSL Behring

CSL Ltd Summary

CSL Ltd [CSL] is traded on Australian Securities Exchange in Australia. It is located in Parkville, VIC and employs 10,515 people. The company currently falls under 'Large-Cap' category with current market capitalization of 29.94 B. CSL Ltd operates under Healthcare sector and is part of Biotechnology industry. This company has 498.19 M outstanding shares.
CSL Limited, a specialty biopharmaceutical company, engages in the research, development, manufacture, marketing, and distribution of biopharmaceutical and allied solutions primarily in Australia, the United States, Switzerland, and Germany. more
Follow CSL Ltd with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add CSL Ltd to your reader
 

CSL Ltd Research Report

CSL Ltd vs. Mesoblast

Correlation analysis and fundamentals comparison between CSL Ltd and Mesoblast Limited

CSL Ltd Executives

Beng Mba CFO
Gordon Naylor CFO - Designate

CSL Ltd Directors

Mbbs, Bmedsci Chief Scientific officer and Director of RandD
Peter Turner Executive Director
Christine OReilly Non-Executive Director
Mark Dehring Director of Investor Relations, IR Contact Officer
Ian Renard Independent Non-Executive Director

CSL Ltd Management

MBA BAppsc Executive VP of Operations

CSL Ltd Fundamentals

Market Capitalization vs Z Score
Net Income vs Return On Equity
Market Capitalization vs One Year Low
Price to Earning vs Return On Equity

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium